Premature ovarian insufficiency: a review on the role of tobacco smoke, its clinical harm, and treatment Original paper
Researched by:
-
Divine Aleru
ID
Divine Aleru
Read MoreI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
-
Women’s Health
Women’s Health
Women’s health, a vital aspect of medical science, encompasses various conditions unique to women’s physiological makeup. Historically, women were often excluded from clinical research, leading to a gap in understanding the intricacies of women’s health needs. However, recent advancements have highlighted the significant role that the microbiome plays in these conditions, offering new insights and potential therapies. MicrobiomeSignatures.com is at the forefront of exploring the microbiome signature of each of these conditions to unravel the etiology of these diseases and develop targeted microbiome therapies.
-
Primary Ovarian Insufficiency (POI)
Primary Ovarian Insufficiency (POI)
Primary Ovarian Insufficiency (POI) is a medical condition in which a woman’s ovaries stop functioning normally before the age of 40. This leads to reduced estrogen production and irregular menstrual cycles, which may eventually result in infertility and early menopause-like symptoms. POI can occur due to various reasons, including genetic factors, autoimmune disorders, chemotherapy, or unknown causes. Though often misunderstood and misdiagnosed, POI can significantly impact a woman's physical and emotional well-being. Early diagnosis and appropriate treatment, including hormone replacement therapy (HRT) and fertility interventions, can help manage symptoms, improve quality of life, and in some cases, restore fertility.
-
Divine Aleru
Read More
Researched by:
-
Divine Aleru
ID
Divine Aleru
Read More
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Divine Aleru
What was studied?
This review investigates the impact of tobacco smoke on premature ovarian insufficiency (POI), a condition characterized by the early depletion of ovarian follicles and the onset of menopause before the age of 40. The study reviews the harmful effects of tobacco-related toxicants such as polycyclic aromatic hydrocarbons (PAHs), heavy metals like cadmium, alkaloids including nicotine and cotinine, and benzo[a]pyrene, all of which contribute to ovarian damage. These toxicants can disrupt ovarian function by promoting apoptosis, oxidative stress, and DNA damage, leading to decreased fertility, early menopause, and a reduction in ovarian reserve.
Who was studied?
The review draws on data from human and animal studies, particularly focusing on the effects of tobacco exposure on women of reproductive age and animal models. The studies cited in the review examine the physiological and molecular consequences of smoking on ovarian tissues, granulosa cells, and oocytes, particularly how they respond to the harmful substances in tobacco smoke.
Most important findings
Tobacco smoke contains more than 5,000 harmful chemicals that damage the ovaries. The review identifies how smoking accelerates ovarian aging by promoting follicular atresia, particularly affecting primordial follicles. It also describes how the exposure leads to persistent oxidative stress, mitochondrial dysfunction, and lipid peroxidation, which impair oocyte quality and reduce fertility. Notably, the review discusses the toxic effects of compounds such as nicotine, cotinine, cadmium, and PAHs on ovarian function. For example, nicotine disrupts estrogen production and hinders follicle development, while PAHs have been shown to reduce follicular growth and cause oocyte dysfunction.
Key implications
The review highlights the need for targeted interventions to reduce smoking among women of reproductive age, given its detrimental effects on ovarian health and fertility. Smoking cessation should be a key focus in the management and prevention of POI. Additionally, the review suggests that antioxidant therapies and other treatments targeting oxidative stress may offer potential therapeutic options for women with POI. The findings also underline the importance of public health efforts to reduce smoking rates, as it is a modifiable risk factor for early menopause and reduced fertility.
Primary Ovarian Insufficiency (POI)
Primary Ovarian Insufficiency (POI) is a medical condition in which a woman’s ovaries stop functioning normally before the age of 40. This leads to reduced estrogen production and irregular menstrual cycles, which may eventually result in infertility and early menopause-like symptoms. POI can occur due to various reasons, including genetic factors, autoimmune disorders, chemotherapy, or unknown causes. Though often misunderstood and misdiagnosed, POI can significantly impact a woman's physical and emotional well-being. Early diagnosis and appropriate treatment, including hormone replacement therapy (HRT) and fertility interventions, can help manage symptoms, improve quality of life, and in some cases, restore fertility.
Menopause
Menopause impacts many aspects of health, including the gut microbiome, weight management, and hormone balance. Diet, probiotics, intermittent fasting, and HRT offer effective management strategies.